Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Biomaterials and regenerative medicine in ophthalmology_Chirila_2010

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
18.34 Mб
Скачать

Tissue engineering of the lens: fundamentals

259

Chanturishvili P (1958) The role of the ectoderm in the development of the crystallin lens. Trans Ophthalmol Soc UK 78:411–438.

Cobo LM, Ohsawa E, Chandler D, Arguello R, George G (1984) Pathogenesis of capsular opacification after extracapsular cataract extraction, an animal model. Ophthalmology

91:857–863.

Cocteau MM, D’Etoille L (1827) Reproduction du crystallin [Experiments relative to the reproduction of the lens]. J Physiol Exp (Paris) 7:30–744.

Coulombre JL, Coulombre AJ (1971) Lens development: V. Histological analysis of the mechanism of lens reconstitution from implants of lens epithelium. J Exp Zool 176:15–24.

Deacon J (1988) Development of an injectable intraocular lens. MSc Thesis, Department of Bioengineering University of Utah.

de Groot JH, van Beijma FJ, Haitjema HJ, Dillingham KA, Hodd KA, Koopmans SA, Norrby S (2001) Injectable intraocular lens materials based upon hydrogels.

Biomacromolecules 2(3):628–634.

Del Rio-Tsonis KD, Tsonis PA (2003) Eye regeneration at the molecular age. Dev Dyn 226:211–224.

Duke-Elder S (Ed.) (1969a) Chapter I in System of Ophthalmology, Vol. XI, Diseases of the Lens and Vitreous: Glaucoma and Hypotony, London, Henry Kimpton, pp. 3–18.

Duke-Elder S (Ed.) (1969b) Chapter V in System of ophthalmology, Vol. XI, Diseases of the Lens and Vitreous: Glaucoma and Hypotony, London, Henry Kimpton, pp. 233–243.

Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 24(12):1317–1325.

Dvir T, Ysur-Gang O, Cohen S (2005) Designer scaffold for tissue engineering and regeneration. Israel J Chem 45:487–494.

Fagerholm PP, Philipson BT (1981) Human lens epithelium in normal and cataractous lenses. Invest Ophthalmol Vis Sci 21:408–414.

Fagerholm PPP (1982) The response of the lens to trauma. Trans Ophthalmol Soc UK 102:369–374.

Foster A (2000) VISION 2020 – the cataract challenge. J Comm Eye Health 13(34):17– 19.

Gindi JJ, Wan WL, Schanzlin DJ (1985) Endocapsular cataract surgery-1. Surgical technique. Cataract, Int J Cataract Surg 2:5–10.

Gunn, M (1888) Growth of new lens fibers after spontaneous absorption of traumatic cataract. Trans Ophthalmol Soc UK 8:126.

Gwon AE (2005) Controlled ocular lens regeneration. US Patent 6,945,971, issued September 20, 2005.

Gwon A (2006) Lens regeneration in mammals: a review. Surv Ophthalmol 51:51–62. Gwon AE (2007) Controlled ocular lens regeneration. US Patent 7,278,990, issued

October 9, 2007.

Gwon A, Gruber L (2005) Tissue engineering of the Lens. In ARVO 2005 Annual Meeting, Ft Lauderdale, FL, Abstract 2871.

Gwon A, Gruber L (2006) Modulating lens regeneration. In ARVO 2006 Annual Meeting, Ft Lauderdale, FL, Abstract 1997.

Gwon A, Gruber L (2007a) Lens regeneration with an injectable polymeric Scaffold. In ARVO 2007 Annual Meeting, Ft Lauderdale, FL, Abstract 5434.

Gwon A, Gruber L (2007b) Engineering of the crystallin lens. In Proceedings of the 7th International Conference on Hyaluron, International Society for the Hyaluroa Sciences (ishas), Charleston, SC.

260 Biomaterials and regenerative medicine in ophthalmology

Gwon A, Gruber L (2008) Modification of a hyaluronic acid scaffold for lens engineering.

In ARVO 2008 Annual Meeting, Ft Lauderdale, Fl, Abstract# 3732.

Gwon A, Kuszak J, Gruber L (1998) Intralenticular implant study in pigmented rabbits: opacity lensmeter assessment. J Cataract Refract Surg 25:268–277.

Gwon A, Enomoto H, Horowitz J, Garner M (1989) Induction of de novo synthesis of crystalline lenses in aphakic rabbits. Exp Eye Res 49:913–926.

Gwon AE, Gruber L, Mundwiler K (1990) A histologic study of lens regeneration in aphakic rabbits. Invest Ophthalmol Vis Sci 31(3):540–547.

Gwon AE, Jones RL, Gruber LJ, Mantras C (1992) Lens regeneration in rabbits measured by image analysis. Invest Ophthalmol Vis Sci 33:201–205.

Gwon A, Mantras C, Gruber L (1993a) Restoring lens capsule integrity enhances lens regeneration in New Zealand albino rabbits and cats. J Cataract Refract Surg 19:735–746.

Gwon A, Mantras C, Gruber L, Cunanan C (1993b) Lens regeneration in NZA rabbits following endocapsular cataract extraction. Invest Ophthalmol 34:2124–2129.

Haefliger E, Parel J-M, Fantes F, Norton EWD, Anderson DR, Forster RK, Hernadez E,

Feuer WJ (1987) Accommodation of an endocapsular silicone lens (Phaco-Ersatz) in the nonhuman primate. Ophthalmology 94:471–477.

Han YK, Kwon JW, Kim JS, Cho CS, Wee WR, Lee JH (2003) In vitro and in vivo study of lens refilling with poloxamer hydrogel. Br J Ophthalmol 87:1399–1402.

Hettlich H-J, Lucke K, Asiyo-Vogel MN, Schulte M, Vogel A (1994) Lens refilling and endocapsular polymerization of an injectable intraocular lens: In vitro and in vivo study of potential risks and benefits. J Cataract Refract Surg 20:115–123.

Hutmacher DW, Goh JCH, Teoh SH (2001) An introduction to biodegradable materials for tissue engineering applications. Ann Acad Med Singapore 30:183–191.

Ito M, Hayashi T, Kuroiwa A, Okamoto M (1999) Lens formation by pigmented epithelial cell reaggregate from dorsal iris implanted into limb blastema in the adult newt. Dev Growth Differ 41:429–440.

Jacob TJC (1987) Human lens epithelial cells in culture: a quantitative evaluation of growth rate and proliferative capacity. Exp Eye Res 45:93–104.

Kessler J (1964) Experiments in refilling the lens. Arch Ophthalmol 71:412–417. Kessler J (1966) Refilling the rabbit lens. Further experiments. Arch Ophthalmol

76:596–598.

Kessler J (1975) Lens refilling and regrowth of lens substance in the rabbit eye. Ann Ophthalmol 7:1059–1062.

Koopmans SA, Terwee T, Barkhof J, Haitjema HJ, Kooijman AC (2003) Polymer refilling of presbyopic human lenses in vitro restores the ability to undergo accommodative changes. Invest Ophthalmol Vis Sci 44(1):250–257.

Koopmans SA, Terwee T, Glasser A, Wendt M, Vilupuru AS, van Kooten TG, Norrby S,

Haitjema HJ, Kooijman AC (2006) Accommodative lens refilling in rhesus monkeys.

Invest Ophthalmol Vis Sci 47(7):2976–2984.

Kwon JW, Han YK, Lee WJ, Cho CS, Paik SJ, Cho DI, Lee JH, Wee WR (2005) Biocompatibility of poloxamer hydrogel as an injectable intraocular lens – A pilot study. J Cataract Refract Surg 31:607–613.

Lang RA (1999) Which factor stimulate lens fiber cell differentiation in vivo? Invest Ophthalmol Vis Sci 40(13):3075–3077.

Loewenhardt (1841) Einige Versuche um die Regeneration der Krystallinse. Neune Notizen von Froriep 19:344.

Lois N, Dawson R, McKinnon AD, Forrester JV (2003) A new model of posterior capsule opacification in rodents. Invest Ophthalmol Vis Sci 44:3450–3457.

Tissue engineering of the lens: fundamentals

261

Lois N, Taylor J, McKinnon AD, Forrester JV (2005) Posterior capsule opacification in mice. Arch Ophthalmol 123:71–77.

Longaker MT, Adzick NS, Hall JL, Stair SE, Crombleholme TM, Duncan BW, Bradley SM, Harrison MR, Stern R (1990) Studies in fetal wound healing, VII. Fetal wound healing may be modulated by hyaluronic acid stimulating activity in amniotic fluid.

J Pediatric Surg 25(4):430–433.

Longaker MT, Adzick NS (1991) The biology of fetal wound healing: A review. Fetal Treatment Program, University of California, San Francisco 94143-0506. Plast Reconstr Surg 87(4):788–798.

Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, Duncan BW, Adzick NS, Verrier ED, Stern R (1989) Studies in fetal wound healing: IV. Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Fetal

Treatment Program, University of California, San Francisco 94143-0506. Ann Surg 210(3):667–672.

Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R (1991) Studies in fetal wound healing: V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Fetal Treatment Program, University of California, San Francisco 94143-0506. Ann Surg 213(4):292–296.

Mahon KA, Chepelinsky AB, Khillan JS, Overbeek PA, Piatigorsky J, Westphal H (1987) Oncogenesis of the lens in transgenic mice. Science 235(4796):1622–1628.

Mann BK (2003) Biologic gels in tissue engineering. Clin Plastic Surg 30:601–609. Mast BA, Flood LC, Haynes JH, DePalma RL, Cohen IK, Diegelman RF, Krummel

TM (1991) Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Division of Pediatric Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA.

Matrix (Germany) 11(1):63–68.

Mayer (1832) Uber die reproduktion der Krystallinse. J Chirurgie Augenheilkunde (Berlin, von Graefe und Walther) 17:524.

McDonnell P, Zarbin M, Green W (1983) Posterior capsule opacification in pseudophakic eyes. Ophthalmology 90:1548–1553.

McDonnell PJ, Stark WJ, Green RG (1984) Posterior capsular opacification: a specular microscopic study. Ophthalmology 9(7):853–856.

Medvedovic M, Tomlinson CR, Call MK, Grogg M, Tsonis PA (2006) Gene expression and discovery during lens regeneration in mouse: regulation of epithelial to mesenchymal transition and lens differentiation. Molecular Vis 12:422–440.

Menko AS (2002) Lens epithelial cell differentiation. Exp Eye Res 75:485–490. doi: 10.1006/exer.2002.2057, available online at http://www.idealibrary.com.

Middlemore R (1832) On the reproduction of the crystalline lens. Lond Med Gaz 10:344–348.

Milliot B (1872) De la regeneration du crystallin chez quelques mammiferes. J Anatomie Physiologie (Paris) 8:1.

Nishi O, Nishi K, Sakanishi K (1998a) Inhibition of migrating lens epithelial cells at the capsular bend created by the rectangular optic edge of a posterior chamber intraocular lens. Ophthalmic Surg Lasers 29:587–594.

Nishi O, Nishi K, Mano C, Ichihara M, Honda T (1998b) Lens refilling with injectable silicone in rabbit eyes. J Cataract Refract Surg 24:975–982.

Norrby S (2005) Injectable polymer. In Refractive Lens Surgery, Berlin Heidelberg, Springer, pp. 173–186.

Ooto S, Hauta M, Honda Y, Kawasaki H, Sasai Y, Takabashi M (2003) Induction of

262 Biomaterials and regenerative medicine in ophthalmology

the differentiation of lentoids from primate embryonic stem cells. Invest Ophthalmol Vis Sci 44:2689–2693.

Parel J-M, Treffers WF, Gelender H, Norton EWD (1981) Phaco-Ersatz: a new approach to cataract surgery. Ophthalmology 88(9), Suppl:95.

Parel J-M, Gelender H, Trefers WF, Norton EWD (1986) Phaco-Ersatz: cataract surgery designed to preserve accommodation. Graefe’s Arch Clin Exp Ophthalmol 224:165–173.

Petit T (1963) A study of lens regeneration in the rabbit. Invest Ophthalmol Vis Sci 2:243–251.

Piatigorsky J (1981) Lens differentiation in vertebrates, a review of cellular and molecular features. Differentiation 19:134–153.

Rafferty NS (1985) Lens morphology. In The Ocular Lens, Maisel H. (Ed.), New York and Basel, Marcel Dekker, Inc. Chapter 1, pp. 1–60.

Randolph RL (1900) The regeneration of the crystalline lens: An experimental study.

Johns Hopkins Hospital Rep 9:237.

Remington SG, Meyer RA (2007), Lens stem cells reside outside the lens capsule: an hypothesis. Theor Biol Med Model 4:22.

Sikharulidze TA (1956) Exchange of crystallin lens in rabbits by embryonic skin ectoderm.

Bull Acad Sci Georg S.S.R. 14:337.

Stern R (2004) Mammalian hyaluronidases. In Hyaluronan Today, Vincent C (Ed.), Hascall/Masaki, Yanagishita, http://www.glycoforum.gr.jp/science/hyaluronan/ hyaluronanE.html.

Stewart DS (1960) Further observations on regenerated crystalline lenses in rabbits, with special reference to their refractive qualities. Trans Ophthalmol Soc UK 80:357.

Stewart DS, ‘Espinasse PG (1959) Regeneration of the lens of the eye in the rabbit.

Nature 183:1815.

Tsonis PA, Rio-Tsonis KD (2004) Lens and retina regeneration: transdifferentiation, stem cells, and clinical applications. Curr Eye Res 78:161–172.

Tsonis PA (2006) How to build and rebuild a lens. J Anat 209:433–437.

Van Alphen GWHM (1959) Transplantation of the lens. Arch Ophthalmol 61:115– 126.

Wong KH, Koopmans SA, Terwee T, Kooijman AC (2007) Changes in spherical aberration after lens refilling with silicone oil. Invest Ophthalmol Vis Sci 48:1261–1267.

Yoo MK, Choi YJ, Lee JH, Wee WR, Cho CS (2007) Injectable intraocular lens using hydrogels. J Drug Deliv Sci Tech 17:81–85.

Zhou M, Leiberman J, Xu J, Lavker RM (2006). A hierarchy of proliferative cells exists in mouse lens epithelium: Implications for lens maintenance. Invest Ophthalmol Vis Sci 47:2997–3003.

10

Bioinspired biomaterials for soft contact lenses

T. Goda, T. Shimizu and K. Ishihara,

The University of Tokyo, Japan

Abstract: This chapter describes representative bioinspired biomaterials, synthetic phospholipid polymers, for use as soft contact lens materials with advanced biocompatibility. The chapter first reviews how the phospholipid polymer was inspired from natural phospholipids in the cell membrane in order to develop biocompatible materials and why the phospholipid polymer shows superior biocompatibility from the physicochemical and biological viewpoints. The chapter then describes the application of materials containing the phospholipid polymer in daily-wear, daily-disposable, extended-wear, and continuous-wear soft contact lenses with enhanced protein repellency, water wettability, and biocompatibility.

Key words: phospholipid polymer, bioinertness, silicone hydrogel, oxygen permeability, water wettability.

10.1Introduction

In many recent clinical trials of artificial materials, very few candidates turned out to be compatible with living organisms and tissues. That is, the living body rejects most of the naturally occurring and synthetically delivered artificial materials by inducing acute biological reactions such as inflammation, immune responses, and blood coagulation; or by producing toxicity, unfavorable deterioration, or corrosion of the materials themselves (Ratner et al., 2004). Besides being biologically compatible, biomaterials must meet several physicochemical requirements for therapeutic use in specific clinical situations. As for soft contact lenses, for example, the fundamental requirements of the candidate material are that they must possess optical properties suitable for vision correction. Hence, it is difficult to develop biomaterials that meet both biological and physicochemical requirements. Therefore, biologically inspired or biomimetic materials that mimic molecular designs, functionality, or nanostructures found in nature have been developed for successful therapeutic application (Shin et al., 2003). Hereafter, we discuss the use of a representative bioinspired material, the phospholipid polymer, as soft contact lens material. The natural properties of the phospholipid polymer make it capable of mediating mild interaction with biomolecules and cell membrane surfaces to prevent undesired biological reactions inside

263

264 Biomaterials and regenerative medicine in ophthalmology

the living body. The bioinertness of this material may be of great use for the development of a soft contact lens material with superior biocompatibility. With the increase in the popularity of contact lenses in the world, great interest has been generated in the potential complications of contact lens usage and in the means to reduce the frequency and severity of such complications. For example, the risk of infectious complications associated with the frequent use of contact lenses results in the pathophysiologic changes that predispose the eye to microbial invasion and replication (Stapleton et al., 2007).

Pseudomonas aeruginosa and Staphylococcus epidermidis are major causative agents of infectious keratitis in patients using soft contact lenses (Ladage et al., 2004). Adhesion of these bacteria to soft contact lenses is influenced by lens surface properties because the adhesion originates in adhesive protein in the extracellular matrices produced by the bacteria themselves. Therefore, the bioinertness of the contact lens material impairs the susceptibility to biofilm formation. In addition, the phospholipid polymer exhibits a good processability, which further justifies its use in the manufacture of soft contact lenses. Introduction of the phospholipid polymer into an appropriate material by means of a wide variety of chemical methods facilitates the regulation of the physicochemical properties required for soft contact lenses.

10.2Bioinspired phospholipid polymer

As described above, biocompatibility is a key criterion for the preparation of biomaterials. Generally, non-specific protein adsorption on to a biomaterial triggers a series of biological cascade reactions (Colman and Schmaier, 1997). The bioinert natural cell membrane surface is the best example of a material capable of preventing non-specific protein adsorption. A cell membrane as a self-assembly with a bilayer structure is organized by amphiphilic phospholipids as a unit in association with membrane proteins, glycoproteins, and glycolipids (Singer and Nicolson, 1972). Of these, phosphatidylcholine is the main component of the phospholipids in the human erythrocyte cell membrane. This compound is composed of a hydrophilic phosphorylcholine headgroup and two hydrophobic long alkyl-chain tails. The hydrophilic headgroup is oriented in the outer leaflet of the erythrocyte, which is believed to prevent non-specific protein adsorption on to the cell membrane. Applying the natural cell membrane itself directly to the biomaterial surface, however, is a problem because the cell membrane cannot be stably immobilized on a material surface for a specific duration because of the weak interaction of the membrane with the material surface and because of the membrane’s selfassembled structure. Furthermore, covalent bonding between the phospholipid molecules is not possible because of their lack of chemical reactivity. This obstacle has been overcome by a chemical innovation. Inspired by the molecular structure of the headgroup in the phosphatidylcholine, a new compound named

Bioinspired biomaterials for soft contact lenses

265

2-methacryloyloxyethyl phosphorylcholine (MPC) was synthesized with the aim of conferring biocompatibility to a material by the stable introduction of the phosphorylcholine headgroup into an artificial material by chemical reactions (Ishihara et al., 1990a) (see Fig. 10.1). Since MPC is a monomeric methacrylate possessing a phosphorylcholine headgroup in the side chain, the bioinspired headgroup can be easily attached to any polymer via conventional polymerization techniques by using suitable monomeric compounds (Iwasaki and Ishihara, 2005). Polymers prepared in this way are called ‘phospholipid polymers’ or ‘MPC polymers’. A wide variety of organic, ceramic, metallic, and composite materials containing a phospholipid polymer have been investigated for clinical application. Previous results indicated that the phospholipid polymer strongly prevents non-specific adsorption of biomolecules under biological environments. In addition, the phospholipid polymer confers water wettability and lubricity to a material surface (Ho et al., 2003). The formation of a hydrated layer around the headgroup markedly reduces friction by fluid lubrication mechanisms and provides excellent wettability at the interface. These key performances of the phospholipid polymer mainly originate in hydrophilicity and electroneutrality due to the zwitterionic structure of the headgroup. In particular, the zwitterionic headgroup has a very minor effect on the structure of the hydrogen-bonding network of water molecules that endow resistance to non-specific adsorption of biomolecules (Ishihara et al., 1998; Kitano et al., 2003). Moreover, the phospholipid polymer does not attract biomolecules with local charges because of the electroneutrality

 

O

 

O

O

P O

N+

O

 

O

O

 

 

O

 

 

 

 

 

 

Cell membrane

 

 

O

 

O

P O

N+

O

O

Bioinspiring

 

 

 

O

 

 

 

 

 

2-Methacryloyloxyethyl phosphorylcholine

Phosphatidylcholine

(MPC)

 

 

 

10.1 Molecular design of MPC as a main component of synthetic phospholipid polymers. The chemical structure of MPC is close to that of phosphatidylcholine. Phospholipid polymers provide biocompatibility by forming stable cell membrane-like interfaces.

266 Biomaterials and regenerative medicine in ophthalmology

of the headgroup due to intramolecular salt formation (Xu et al., 2007). The electroneutrality of the phosphorylcholine group may also stabilize the dimensions and solubility of poly(MPC) regardless of the ionic strength in the aqueous media (Matsuda et al., 2006). In the following section, we describe the use of the bioinspired phospholipid polymer for enhancement of biocompatibility and wettability; these factors being strongly related to comfort issues of soft contact lenses.

10.3Requirements for biocompatible soft contact lenses

Before describing the applications of the phospholipid polymer for soft contact lenses, let us review the conditions necessary for designing soft contact lens materials. The candidate polymer must satisfy the following requirements: the material must be transparent with suitable optical properties such as transparency and sphere power availability, must possess chemical and thermal stability, and must exhibit a high tensile and tear strength for lenshandling durability. In addition, since the material is directly in touch with the corneal epithelium, the material should be wettable to allow coverage with tear film, biocompatible, protein adsorption-resistive, electrolyte permeable, and oxygen permeable so as to avoid insult to the eye tissue. The potential hydrophobicity of a material increases the risk of dehydration of the lens as well as excessive lipid deposition. Protein adsorption on lenses concurrently decreases visual acuity, makes the lenses uncomfortable, and also reduces the wear lifetime. The contact lenses should transmit as much oxygen from the atmosphere into corneal tissues as in a no-lens situation (at least 87 barrer/mm) because, owing to the lack of blood circulation in transparent cornea, insufficient oxygen transport through the lens causes corneal edema resulting in a number of adverse physiological responses, such as excessive corneal swelling in overnight wear (Harvitt and Bonanno, 1999). Finally, from the manufacturer’s viewpoint, the material must be suitable for bulk polymerization and for manufacture using current production techniques.

The importance of the irreversible interaction of tear components with soft contact lenses has long been recognized. Two of the most significant variables in the development of lens biofouling are duration of wear and individual patient tear chemistry. The wear period is now much more carefully controlled with the advent of daily-wear disposable soft contact lenses. However, the development of materials with enhanced antibiofouling properties needs further improvement. The contributions of the material’s surface to the inflammatory response is becoming increasingly important with the advent of continuous-wear and long-term-wear soft contact lenses, as previously mentioned in the Introduction. Adhesions and activations of neutrophils are affected by surface characteristics which, in turn, influence

Bioinspired biomaterials for soft contact lenses

267

the inflammatory response to the lens. Bacterial adhesion to soft contact lens materials is the first stage in contact lens-associated microbial keratitis, which may ultimately lead to corneal ulceration. The candidate materials should possess protein adsorption resistance, biocompatibility, and tear wettability as well as bulk polymer characteristics for continuous and extended wear. Thus, the use of a bioinspired phospholipid polymer is one of the effective ways to enhance the antifouling properties and biocompatibility of the lens. Recently, soft contact lenses have been developed mainly for use as daily, daily disposable, extended, and continuous wear. The phospholipid polymer has succeeded in enhancing the overall biocompatibility of all types of soft contact lenses, as described in the following sections.

10.4Phospholipid polymer for daily-wear soft contact lenses

Daily-wear soft contact lenses with routine maintenance have a longer history of use than the other types of lenses. They have been available since the development of poly(2-hydroxyethyl methacrylate) (poly(HEMA)) hydrogels as a soft contact lens material (Wichterle and Lim, 1960). The hydrogel contains 38% water, has reasonable wettability, and offers the wearer comfort. Various types of derivative hydrogels containing different hydrophilic monomer units – such as methacrylic acid, N-vinylpyrrolidinone (NVP), and glyceryl methacrylate – have been developed with increased water content, subsequent oxygen permeability, and surface water wettability. Many attempts have focused on the enhancement of oxygen transport by either using a hydrophilic polymer or by making the hydrogel lens thinner. However, these hydrogels did not generate ideal results because of the induction of mechanical weakness and a tendency to adsorb tear proteins and lipids. For example, US Food and Drug Administration (FDA) II Group materials that contain NVP tend to adsorb more lipids than other conventional soft contact lens materials (Jones et al., 1997). Spoliation occurs more easily for materials with higher water content, not because of the water content itself, but because of the presence of NVP. In addition, soft contact lenses with relatively high water content tend to increase the occurrence of bacterial adhesion (Dang et al., 2003). In the case of ionic materials, e.g. methacrylic acid which is commonly introduced to elevate the oxygen permeability, lysozyme – a major protein of the tear fluid working as an enzyme that damages the bacterial cell wall by catalyzing hydrolysis of peptidoglycan and chitodextrins − is extensively adsorbed on materials that contain carboxylate groups (Keith et al., 2003). Lysozyme adsorption should originate in the electrostatic attraction between the negatively charged methacrylic acid and the positively charged lysozyme. Although it has been reported that the adsorbed lysozyme on the lens does not generate an adverse clinical reaction owing to the enzyme’s

268 Biomaterials and regenerative medicine in ophthalmology

antibacterial effects, the electrostatically attached lysozyme on the lens surface may not be as effective for its original function as an enzyme. Furthermore, the adsorbed lysozyme has to be completely washed away once the contact lenses are removed from the eyes because it may cause bacterial contamination of the lenses. Such a routine is not only a great inconvenience for wearers, but may also increase the potential risk of infectious eye diseases such as microbial keratitis.

Phospholipid polymers have been introduced into conventional soft contact lens material. The US company CooperVision produces a soft contact lens material containing MPC units (Proclear®, omafilcon A) that is categorized in the FDA II Group (Fig. 10.2). This hydrogel is made of a cross-linked random copolymer of HEMA and MPC (Taddei et al., 2005). The water content and oxygen permeability of this hydrogel are 62% and 33 barrers, respectively. Researchers discovered that good mechanical characteristics were obtained while still achieving moderate oxygen permeability that maintained corneal health during wear. Poly(HEMA-co-MPC) hydrogel soft contact lenses offer a high level of bioinertness due to a poor adhesion of the eukaryotic cells of the corneal epithelium to the bioinspired surface. The anti-adhesive ability also impairs susceptibility to bacterial attachment and biofilm formation on soft contact lenses. Soft contact lenses made of omafilcon A were less susceptible to biofilm formation by S. epidermidis or

P. aeruginosa in in vitro experiments (Selan et al., 2009). An increase in the antibiotic susceptibility of bacterial clusters is associated with diminished bacterial adhesion. The enhancement of the anti-adhesion property against biomolecules and cells should result in superior protein adsorption resistance of the MPC unit due to the creation of a cell membrane analogous interface

(

HEMA (

(

MPC (

O

OH

 

 

 

O

O

 

 

 

O

P O

N+

 

O

 

O

O

 

10.2 Chemical structure of Proclear® soft contact lens (omafilcon A). The bulk material is a cross-linked copolymer hydrogel of HEMA and MPC.